During the past decade, Bravis Ziekenhuis conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 6 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bravis Ziekenhuis" #1 sponsor was "Radboud University Medical Center" with 6 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "The Netherlands Cancer Institute" with 3 trials sponsored, "University Medical Center Groningen" with 3 trials sponsored and "Zimmer Biomet" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bravis Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 4 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Dutch Kidney Foundation" with 2 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Bravis Ziekenhuis" are "Colorectal Cancer" (3 trials), "Acute Myocardial Infarction" (2 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials) and "Failed Back Surgery Syndrome" (2 trials). Many other conditions were trialed in "Bravis Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Bravis Ziekenhuis" are "Drug" (27 trials), "Other" (7 trials), "Device" (6 trials), "Procedure" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bevacizumab" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "5-fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bravis Ziekenhuis" are 39 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Bravis Ziekenhuis". undefined are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 21 completed trials in Bravis Ziekenhuis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bravis Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".